
浏览全部资源
扫码关注微信
1.广西中医药大学研究生院, 南宁 530001
2.广西中医药大学第二附属医院骨科,南宁 530011
3.广西中医药大学第一附属医院骨科, 南宁 530023
住院医师,博士研究生。研究方向:脊柱、骨关节相关疾病的中西医结合治疗。E-mail:361216794@qq.com
主治医师,博士研究生。研究方向:脊柱、骨关节相关疾病的中西医结合治疗。E-mail:drxiaofei2020@163.com
收稿:2026-02-13,
修回:2026-07-11,
录用:2026-07-13,
网络首发:2026-07-24,
纸质出版:2026-07-30
移动端阅览
黄玉文,洪智涛,黄永原,等.3种关节内注射药物治疗膝骨关节炎长期疗效的网状Meta分析 [J].中国药房,2026,37(14):1905-1911.
HUANG Yuwen,HONG Zhitao,HUANG Yongyuan,et al.Long-term efficacy of three intra-articular injections in the treatment of knee osteoarthritis: a network meta-analysis[J].ZHONGGUO YAOFANG,2026,37(14):1905-1911.
黄玉文,洪智涛,黄永原,等.3种关节内注射药物治疗膝骨关节炎长期疗效的网状Meta分析 [J].中国药房,2026,37(14):1905-1911. DOI: 10.6039/j.issn.1001-0408.2026.14.18.
HUANG Yuwen,HONG Zhitao,HUANG Yongyuan,et al.Long-term efficacy of three intra-articular injections in the treatment of knee osteoarthritis: a network meta-analysis[J].ZHONGGUO YAOFANG,2026,37(14):1905-1911. DOI: 10.6039/j.issn.1001-0408.2026.14.18.
目的
2
评价关节内注射透明质酸(HA)、富血小板血浆(PRP)、自体微碎脂肪组织(MFAT)治疗膝骨关节炎(KOA)的长期疗效。
方法
2
检索PubMed、Web of Science、Embase、Cochrane Library、中国知网、万方数据、维普网和中国生物医学文献服务系统以及各临床试验注册平台,收集KOA患者关节内注射上述3种药物的随机对照试验(RCT),检索时限为2016年1月至2025年12月。筛选文献、提取数据和评价纳入文献质量后,采用RevMan 5.3、Stata MP 16.0软件进行网状Meta分析。
结果
2
共纳入31篇RCT,共计2 964例患者。在缓解疼痛方面,PRP+HA、PRP治疗后6个月时患者的视觉模拟评分法(VAS)评分均显著低于生理盐水和HA治疗者(
P
<0.05),累积排序曲线下面积(SUCRA)排名前2位的是PRP+HA、PRP;PRP治疗后12个月时患者的VAS评分显著低于HA和生理盐水治疗者(
P
<0.05),SUCRA排名前2位的是PRP、PRP+HA。在功能改善方面,PRP治疗后6个月,MFAT、PRP、PRP+HA治疗后12个月时患者的西安大略和麦克马斯特大学骨关节炎指数(WOMAC)评分均显著低于HA或生理盐水治疗者(
P
<0.05);MFAT、PRP治疗后6、12个月时患者的国际膝关节文献委员会(IKDC)评分显著高于生理盐水治疗者(
P
<0.05),PRP治疗后12个月时患者的IKDC评分显著高于HA治疗者(
P
<0.05);WOMAC评分、IKDC评分SUCRA排名前2位的均为MFAT、PRP。
结论
2
缓解疼痛方面,PRP+HA治疗后6个月时优势显著,单用PRP在治疗后12个月时具有潜在优势;功能改善方面,MFAT在治疗后6个月和12个月时显示出显著优势。
OBJECTIVE
2
To evaluate the long-term efficacy of intra-articular injection of hyaluronic acid (HA), platelet-rich plasma (PRP), and micro-fragmented adipose tissue (MFAT) in treatment of knee osteoarthritis (KOA).
METHODS
2
Randomized controlled trials (RCTs) of KOA patients receiving intra-articular injection of the three agents were collected from PubMed, Web of Science, Embase, Cochrane Library, CNKI, Wanfang Data, VIP, Chinese Biomedical Literature Service System,and clinical trial registration platforms. The retrieval time limit was from January 2016 to December 2025. After screening the literature, extracting the data,and evaluating the quality of the literature, network meta-analysis was performed using RevMan 5.3 and Stata MP 16.0 software.
RESULTS
2
A total of 31 RCTs involving 2 964 patients were included. For pain relief, after 6 months of treatment, the Visual Analogue Scale (VAS) scores in the PRP+HA and PRP groups were significantly lower than those in the saline and HA groups (
P
<0.05), PRP+HA and PRP were ranked as the top two by surface under the cumulative ranking curve (SUCRA). After 12 months of treatment, the VAS scores in the PRP group were significantly lower than those in the HA and saline groups (
P
<0.05), PRP and PRP+HA were ranked as the top two by SUCRA. For functional recovery, after 6 months of treatment, the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) scores in the PRP group were significantly lower than those in the HA or saline groups (
P
<0.05). After 12 months of treatment, the WOMAC scores in the MFAT, PRP and PRP+HA groups were significantly lower than those in the HA or saline groups (
P
<0.05). After 6 and 12 months of treatment, International Knee Documentation Committee (IKDC) scores in the MFAT and PRP groups were significantly higher than the saline group (
P
<0.05), and after 12 months of treatment, the PRP group was significantly higher than the HA group (
P
<0.05). MFAT and PRP were ranked as the top two by SUCRA for both the WOMAC and IKDC scores.
CONCLUSIONS
2
For pain relief, PRP+HA showed a significant advantage at 6 months after treatment, whereas PRP alone demonstrated a notable superiority at 12 months after treatment. For functional recovery, MFAT exhibited a marked advantage at both 6 and 12 months after treatment.
Bennell K L , Paterson K L , Metcalf B R , et al . Effect of intra-articular platelet-rich plasma vs placebo injection on pain and medial tibial cartilage volume in patients with knee osteoarthritis:the RESTORE randomized clinical trial [J ] . JAMA , 2021 , 326 ( 20 ): 2021 - 2030 .
Bansal H , Leon J , Pont J L , et al . Platelet-rich plasma(PRP)in osteoarthritis(OA) knee:correct dose critical for long term clinical efficacy [J ] . Sci Rep , 2021 , 11 ( 1 ): 3971 .
Ahmad Raeissadat S , Ghazi Hosseini P , Bahrami M H , et al . The comparison effects of intra-articular injection of platelet rich plasma(PRP),plasma rich in growth factor(PRGF),hyaluronic acid(HA),and ozone in knee osteoarthritis;a one year randomized clinical trial [J ] . BMC Musculoskelet Disord , 2021 , 22 ( 1 ): 134 .
Gupta N , Khatri K , Lakhani A , et al . Long-term effectiveness of intra-articular injectables in patients with knee osteoarthritis:a systematic review and Bayesian network meta-analysis [J ] . J Orthop Surg Res , 2025 , 20 ( 1 ): 227 .
Xu Z , He Z X , Shu L P , et al . Intra-articular platelet-rich plasma combined with hyaluronic acid injection for knee osteoarthritis is superior to platelet-rich plasma or hyalu-ronic acid alone in inhibiting inflammation and improv-ing pain and function [J ] . Arthrosc J Arthrosc Relat Surg , 2021 , 37 ( 3 ): 903 - 915 .
Park Y B , Lee S K , Kim K I , et al . Microfragmented adipose tissue as an alternative to platelet-rich plasma for intra-articular injection in knee osteoarthritis:a systematic review and meta-analysis of randomized controlled trials [J ] . Am J Sports Med , 2025 , 53 ( 14 ): 3554 - 3564 .
Kolasinski S L , Neogi T , Hochberg M C , et al . 2019 American College of Rheumatology/Arthritis Foundation guideline for the management of osteoarthritis of the hand,hip,and knee [J ] . Arthritis Rheumatol , 2020 , 72 ( 2 ): 220 - 233 .
Bannuru R R , Osani M C , Vaysbrot E E , et al . OARSI guidelines for the non-surgical management of knee,hip,and polyarticular osteoarthritis [J ] . Osteoarthritis Cartilage , 2019 , 27 ( 11 ): 1578 - 1589 .
Higgins J P T , Altman D G , Gotzsche P C , et al . The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials [J ] . BMJ , 2011 , 343 : d5928 .
张天嵩 . Stata软件network组命令在网状Meta分析中的应用 [J ] . 中国循证医学杂志 , 2015 , 15 ( 11 ): 1352 - 1356 .
Li T S , Li Y F , Li W Y , et al . Impact of autologous platelet-rich plasma therapy vs. hyaluronic acid on synovial fluid biomarkers in knee osteoarthritis:a randomized controlled clinical trial [J ] . Front Med , 2023 , 10 : 1258727 .
Wang Z M , Wang R , Xiang S C , et al . Assessment of the effectiveness and satisfaction of platelet-rich plasma compared with hyaluronic acid in knee osteoarthritis at minimum 7-year follow-up:a post hoc analysis of a ran-domized controlled trial [J ] . Front Bioeng Biotechnol , 2022 , 10 : 1062371 .
Zaffagnini S , Andriolo L , Boffa A , et al . Microfragmented adipose tissue versus platelet-rich plasma for the treatment of knee osteoarthritis:a prospective randomized controlled trial at 2-year follow-up [J ] . Am J Sports Med , 2022 , 50 ( 11 ): 2881 - 2892 .
Kaszyński J , Bąkowski P , Kiedrowski B , et al . Intra-articular injections of autologous adipose tissue or platelet-rich plasma comparably improve clinical and functional outcomes in patients with knee osteoarthritis [J ] . Biomedicines , 2022 , 10 ( 3 ): 684 .
Gobbi A , Dallo I , D’Ambrosi R . Autologous microfragmented adipose tissue and leukocyte-poor platelet-rich plasma combined with hyaluronic acid show comparable clinical outcomes for symptomatic early knee osteoarthritis over a two-year follow-up period:a prospective randomized clinical trial [J ] . Eur J Orthop Surg Traumatol , 2023 , 33 ( 5 ): 1895 - 1904 .
Baria M , Barker T , Durgam S , et al . Microfragmented adipose tissue is equivalent to platelet-rich plasma for knee osteoarthritis at 12 months posttreatment:a randomized controlled trial [J ] . Orthop J Sports Med , 2024 , 12 ( 3 ): 23259671241233916 .
Richter D L , Harrison J L , Faber L , et al . Microfragmented adipose tissue injection reduced pain compared with a saline control among patients with symptomatic osteoarthritis of the knee during 1-year follow-up:a ran-domized controlled trial [J ] . Arthrosc J Arthrosc Relat Surg , 2025 , 41 ( 2 ): 248 - 260 .
王成 , 卢超 . 自体脂肪微片段治疗膝关节骨性关节炎的疗效观察 [J ] . 当代医药论丛 , 2023 , 21 ( 18 ): 45 - 49 .
Lana J F , Weglein A , Sampson S E , et al . Randomized controlled trial comparing hyaluronic acid,platelet-rich plasma and the combination of both in the treatment of mild and moderate osteoarthritis of the knee [J ] . JSRM , 2016 , 12 ( 2 ): 69 - 78 .
Duymus T M , Mutlu S , Dernek B , et al . Choice of intra-articular injection in treatment of knee osteoarthritis:platelet-rich plasma,hyaluronic acid or ozone options [J ] . Knee Surg Sports Traumatol Arthrosc , 2017 , 25 ( 2 ): 485 - 492 .
Buendía-López D , Medina-Quirós M , Fernández-Villacañas Marín M Á . Clinical and radiographic comparison of a single LP-PRP injection,a single hyaluronic acid injection and daily NSAID administration with a 52-week follow-up:a randomized controlled trial [J ] . J Orthop Traumatol , 2018 , 19 ( 1 ): 3 .
di Martino A , di Matteo B , Papio T , et al . Platelet-rich plasma versus hyaluronic acid injections for the treatment of knee osteoarthritis:results at 5 years of a double-blind,randomized controlled trial [J ] . Am J Sports Med , 2019 , 47 ( 2 ): 347 - 354 .
Huang Y , Liu X L , Xu X L , et al . Intra-articular injections of platelet-rich plasma,hyaluronic acid or corticosteroids for knee osteoarthritis [J ] . Der Orthopäde , 2019 , 48 ( 3 ): 239 - 247 .
Lin K Y , Yang C C , Hsu C J , et al . Intra-articular injection of platelet-rich plasma is superior to hyaluronic acid or saline solution in the treatment of mild to moderate knee osteoarthritis:a randomized,double-blind,triple-parallel,placebo-controlled clinical trial [J ] . Arthroscopy , 2019 , 35 ( 1 ): 106 - 117 .
Chu J B , Duan W F , Yu Z Q , et al . Intra-articular injections of platelet-rich plasma decrease pain and improve functional outcomes than sham saline in patients with knee osteoarthritis [J ] . Knee Surg Sports Traumatol Arthrosc , 2022 , 30 ( 12 ): 4063 - 4071 .
Branch E A , Cook J J , Cohen A , et al . Platelet-rich plasma is similar to platelet-rich plasma plus hyaluronic acid for the treatment of knee osteoarthritis at 2 years:a ran-domized controlled trial [J ] . J Cartil Jt Preserv , 2023 , 3 ( 4 ): 100129 .
Fossati C , Randelli F M N , Sciancalepore F , et al . Efficacy of intra-articular injection of combined platelet-rich-plasma(PRP) and hyaluronic acid(HA) in knee degenerative joint disease:a prospective,randomized,double-blind clinical trial [J ] . Arch Orthop Trauma Surg , 2024 , 144 ( 11 ): 5039 - 5051 .
Zhang M , Chew K , Goh P , et al . Clinical efficacy of platelet-rich plasma and hyaluronic acid versus hyaluronic acid for knee osteoarthritis with MRI analysis:a ran-domized controlled trial [J ] . J Clin Med , 2025 , 14 ( 10 ): 3553 .
袁林 , 郭燕庆 , 于洪波 , 等 . 富血小板血浆治疗Ⅱ~Ⅲ期膝骨关节炎的疗效评价 [J/O L ] . 中华关节外科杂志 (电子版), 2016 , 10 ( 4 ): 386 - 392 . https://www.cnki.com.cn/Article/CJFDTotal-ZHGJ201604006.htm https://www.cnki.com.cn/Article/CJFDTotal-ZHGJ201604006.htm . DOI: 10.3877/cma.j.issn.1674-134X.2016.04.006 http://dx.doi.org/10.3877/cma.j.issn.1674-134X.2016.04.006 .
翟文亮 , 周亮 , 刘晖 , 等 . 富血小板血浆与透明质酸钠治疗膝关节骨关节炎的临床观察 [J/OL ] . 中华关节外科杂志 (电子版), 2017 , 11 ( 1 ): 96 - 100 . https://www.sinomed.ac.cn/article.do?ui=2017235923 https://www.sinomed.ac.cn/article.do?ui=2017235923 . DOI: 10.3877/cma.j.issn. 1674-134X.2017.01.019 http://dx.doi.org/10.3877/cma.j.issn.1674-134X.2017.01.019 .
孙波 , 李新炜 . 富血小板血浆和玻璃酸钠在膝关节退变治疗应用中的对比研究 [J ] . 中国伤残医学 , 2018 , 26 ( 17 ): 10 - 12 .
郭燕庆 , 于洪波 , 孟勇 , 等 . 应用富血小板血浆混合透明质酸钠治疗膝骨关节炎 [J/OL ] . 中华关节外科杂志 (电子版), 2018 , 12 ( 6 ): 874 - 878 . https://rs.yiigle.com/cmaia/1112109 https://rs.yiigle.com/cmaia/1112109 . DOI: 10.3877//.cma.j.issn.1674-134X.2018.06.023 http://dx.doi.org/10.3877//.cma.j.issn.1674-134X.2018.06.023 .
侯威 , 张卫 , 周淑平 . 注射PRP与透明质酸治疗膝骨关节炎的研究 [J ] . 基因组学与应用生物学 , 2019 , 38 ( 12 ): 5676 - 5683 .
邓欢 , 龚礼 , 周明 , 等 . 关节腔注射富血小板与玻璃酸钠治疗膝关节骨性关节炎的长期疗效比较 [J ] . 江西医药 , 2020 , 55 ( 12 ): 1770 - 1773,1780 .
刘燕 , 徐鹏 , 藏剑 , 等 . 富血小板血浆联合玻璃酸钠关节腔注射治疗膝骨关节炎的临床效果 [J ] . 临床合理用药 , 2023 , 16 ( 34 ): 87 - 90 .
马聪 , 李雪靖 , 郑晓佐 , 等 . 关节腔内注射富血小板血浆与透明质酸钠治疗Ⅰ~Ⅲ期膝骨关节炎的对比研究 [J/OL ] . 中华老年骨科与康复电子杂志 , 2023 , 9 ( 5 ): 282 - 288 . https://zhlngkykfdzzz.cma-cmc.com.cn/CN/10.3877/cma.j.issn.2096-0263.2023.05.005 https://zhlngkykfdzzz.cma-cmc.com.cn/CN/10.3877/cma.j.issn.2096-0263.2023.05.005 .
孟勇 , 庄全魁 , 陈勇 , 等 . 可视化自体富血小板血浆关节腔注射对轻中度膝骨关节炎患者疼痛及关节功能影响 [J ] . 临床军医杂志 , 2024 , 52 ( 4 ): 390 - 392 .
0
浏览量
1
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621